Siglec-7/-9 ligands shield tumor cells from NK cell attack. (7th November 2013) - Jandus, Camilla; Boligan, Kayluz Frias; Chijioke, Obinna; Liu, He; Dahlhaus, Meike; Démoulins, Thomas; Schneider, Christoph; Wehrli, Marc; Hunger, Robert E; Baerlocher, Gabriela M; Simon, Hans-Uwe; Romero, Pedro; et al.